Longevity Health Holdings, Inc.

XAGE Consumer Defensive Household & Personal Products

Longevity Health Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, up 3,702.8% from fiscal 2024.

Revenue
−21.4%
EPS
+51.3%
Free cash flow
+73.2%

Quarter to June 2026, against a year earlier

0.11 0.00 0.00%
Market cap
$1.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
−56.91
Beneish M
22.85
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

142.66% 130.54% 127.68% 109.80%
ROA
(199.84%) (359.56%) (274.36%) (286.02%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
147.83% 117.75% 97.61% 77.54%
Average Days of Receivables
87.26 6.96 9.91 4.22
Free Cash Flow per Share
(2.23) (2.34) (1.61) (0.99)
Free Cash Flow
(3.84) (3.34) (3.06) (2.45)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026